🧬 Bispecific antibodies are reshaping R/R multiple myeloma care. Explore the latest clinical trial data, tackle real-world barriers to implementation, and learn how to personalize therapy while managing AEs. 🩸 Advance your approach—join us! mdsc.pe/3Sy3Apg
#ASH26
#ASH26